Your browser doesn't support javascript.
loading
Computing the relative binding affinity of ligands based on a pairwise binding comparison network.
Yu, Jie; Li, Zhaojun; Chen, Geng; Kong, Xiangtai; Hu, Jie; Wang, Dingyan; Cao, Duanhua; Li, Yanbei; Huo, Ruifeng; Wang, Gang; Liu, Xiaohong; Jiang, Hualiang; Li, Xutong; Luo, Xiaomin; Zheng, Mingyue.
Affiliation
  • Yu J; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Li Z; School of Information Science and Technology, Shanghai Tech University, Shanghai, China.
  • Chen G; Lingang Laboratory, Shanghai, China.
  • Kong X; College of Computer and Information Engineering, Dezhou University, Dezhou City, China.
  • Hu J; Development Department, Suzhou Alphama Biotechnology Co., Ltd, Suzhou City, China.
  • Wang D; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Cao D; University of Chinese Academy of Sciences, Beijing, China.
  • Li Y; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, China.
  • Huo R; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wang G; University of Chinese Academy of Sciences, Beijing, China.
  • Liu X; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Jiang H; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Li X; Lingang Laboratory, Shanghai, China.
  • Luo X; Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Zheng M; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Nat Comput Sci ; 3(10): 860-872, 2023 Oct.
Article in En | MEDLINE | ID: mdl-38177766
ABSTRACT
Structure-based lead optimization is an open challenge in drug discovery, which is still largely driven by hypotheses and depends on the experience of medicinal chemists. Here we propose a pairwise binding comparison network (PBCNet) based on a physics-informed graph attention mechanism, specifically tailored for ranking the relative binding affinity among congeneric ligands. Benchmarking on two held-out sets (provided by Schrödinger and Merck) containing over 460 ligands and 16 targets, PBCNet demonstrated substantial advantages in terms of both prediction accuracy and computational efficiency. Equipped with a fine-tuning operation, the performance of PBCNet reaches that of Schrödinger's FEP+, which is much more computationally intensive and requires substantial expert intervention. A further simulation-based experiment showed that active learning-optimized PBCNet may accelerate lead optimization campaigns by 473%. Finally, for the convenience of users, a web service for PBCNet is established to facilitate complex relative binding affinity prediction through an easy-to-operate graphical interface.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Discovery / Molecular Dynamics Simulation Language: En Journal: Nat Comput Sci Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Discovery / Molecular Dynamics Simulation Language: En Journal: Nat Comput Sci Year: 2023 Document type: Article Affiliation country: Country of publication: